Tran Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$276K Sell
230
-896
-80% -$915K 0.03% 62
2026
Q1
$1.04M Hold
1,126
0.14% 45
2025
Q4
$1.21M Hold
1,126
0.14% 43
2025
Q3
$859K Hold
1,126
0.1% 46
2025
Q2
$878K Hold
1,126
0.1% 43
2025
Q1
$930K Hold
1,126
0.13% 41
2024
Q4
$869K Sell
1,126
-1,608
-59% -$1.33M 0.1% 41
2024
Q3
$2.42M Buy
+2,734
New +$2.46M 0.26% 31

Other funds holding LLY

Tran Capital Management's LLY Position: Q2 2026 in Review

Tran Capital Management reduced its Eli Lilly (LLY) stake by 80% in Q2 2026, selling an estimated $915K and leaving 230 shares worth $276K. The position accounts for 0.03% of the portfolio, ranked #62.

Tran Capital Management first reported a position in LLY in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.42M in Q3 2024. 1,844 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Tran Capital Management held 230 shares of Eli Lilly worth $276K as of Q2 2026.
  • Tran Capital Management sold 896 Eli Lilly shares in Q2 2026, an estimated $915K.
  • Eli Lilly made up 0.03% of Tran Capital Management's portfolio in Q2 2026, its #62 holding.
  • Tran Capital Management first reported a position in Eli Lilly in Q3 2024 and has held it in 8 quarters since.
  • Tran Capital Management's Eli Lilly position peaked at $2.42M in Q3 2024.
  • 1,844 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Tran Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.